Neptune Health and Wellness has received approval to transition one of its facilities for the production of hand sanitizer, the company announced today.
The US Food and Drug Administration has issued another warning letter on COVID-19 claims. This one was issued to a Nevada company marketing CBD products.
Consumers seem to be turning to hemp and cannabis products during the current crisis, which has buoyed the near term outlook for Curaleaf, one of the largest companies in the sector, which posted strong revenue growth in its recent annual report.
A recent paper detailing potential supplement-drug interactions gives a good overview of the issue without overemphasizing the potential safety concerns, an industry expert says.
The increasing popularity of cannabidiol (CBD) only underscores the need for accurate and informative labeling of hemp and hemp-derived CBD products, according to researchers.
CBD firm Charlotte’s Web reported $94.6 million in revenue in its annual report and announced an acquisition that expands its distribution into topical products.
The Natural Products Association (NPA) recently held a webinar on political and legislative insights. At the forefront — the expansion of health savings accounts, new dietary new dietary ingredient enforcement, DSHEA, accurate labels, and Cannabidiol...
The side effects of cannabidiol (CBD) products are ‘most probably’ due to native THC contamination rather than by direct action of CBD or its chemical transformation, according to a German-led study.
CBD has become one of the most mentioned health trends on social media, and according to research by Babylon Health, it also has the most research breadth behind it compared to other popular wellness fads such as 'clean beauty' and 'holistic...
The German Food and Agriculture Ministry (BMEL) has refuted an EU hemp group missive that the Ministry had changed its position regarding the novel food requirement for some cannabidiol (CBD) extracts in the EU.
By Hank Schultz, Elaine Watson and Elizabeth Crawford
A report on CBD delivered by FDA Commissioner Dr Stephen Hahn, MD, was seen by food and dietary supplement industry stakeholders as offering little hope of a timely regulatory solution for the ingredient.
NutraIngredients-USA will investigate the latest news at the upcoming Expo West trade show while at the same time trying not to get distracted by the weight of current events.
FDA Commissioner Dr Stephen Hahn, MD, in a speech on Wednesday, said that despite its continued concern about insufficient safety data, the FDA has no plans to try to shut down the CBD markets. Hahn said that would amount to a “fool’s game.”
